首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Biometrics

缩写:BIOMETRICS

ISSN:0006-341X

e-ISSN:1541-0420

IF/分区:1.6/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引2842
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yue Wang,Bin Nan,Daniel L Gillen et al. Yue Wang et al.
We consider a new nonparametric method for analyzing the onset of a chronic condition, e.g., dementia, when death occurs frequently in the study population. In contrast to the commonly used semi-competing risks or illness-death model, we st...
Zi Wang,Yu Cheng,Abdus S Wahed Zi Wang
Sequential multiple assignment randomized trials (SMARTs) mimic the actual treatment processes experienced by physicians and patients in clinical settings and inform the comparative effectiveness of dynamic treatment regimes. In such trials...
Gabriel Loewinger,Alexander W Levis,Erjia Cui et al. Gabriel Loewinger et al.
Longitudinal binary or count functional data are common in neuroscience, but are often too large to analyze with existing functional regression methods. We propose one-step penalized generalized estimating equations that support generalized...
Justin M Clark,Kollin W Rott,James S Hodges et al. Justin M Clark et al.
Recent work has made important contributions to the development of causally-interpretable meta-analysis. These methods transport treatment effects estimated in a collection of randomized trials to a target population of interest. Ideally, e...
Shuang Sun,Leheng Cai,Qirui Hu Shuang Sun
We develop a statistical framework of inference for mean functions of partially observed functional time series. In the ideal case where curves are fully recorded during the observation period without noise, we establish the weak convergenc...
Zhichen Xu,Jimin Ding,Xiaogang Su et al. Zhichen Xu et al.
In precision medicine, subgroup identification is crucial for designing personalized treatments. This research focuses on subgroup identification in longitudinal clinical trials by integrating the Interaction Tree (ITree) with the Mixed Mod...
Marco Alfó,Maria Francesca Marino,Francesca Martella Marco Alfó
Longitudinal studies give the chance to control for time-constant heterogeneity by adding unit-specific effects to the model formulation. When a random effect specification is adopted, issues of endogeneity may arise. We discuss quantile re...
Wentao Yang,Rongji Mu,Zhangsheng Yu Wentao Yang
Delayed outcomes, such as late-onset toxicity and efficacy, present substantial challenges in dose optimization during Bayesian phase I/II platform trials for drug therapies across multiple indications. To address these challenges and ensur...
Jingru Zhang,Erjia Cui,Hongzhe Li et al. Jingru Zhang et al.
We thank the discussants for their insightful comments and suggestions. In this rejoinder, we clarify the scope of the INTACT framework and discuss several important extensions motivated by the discussion. We address issues related to model...